Does Higher CAG Repeat Mean Worse Spinocerebellar Ataxia?

Generally, yes. A higher number of CAG repeats is strongly linked to an earlier age when symptoms first begin, and it can also indicate that the disease may progress more rapidly ^[1][2]. However, while the repeat number is a very important piece of the puzzle, it is not the only factor that determines how your condition will unfold.

Understanding the Terminology and Numbers

Before diving into what your numbers mean, it helps to understand the terminology. You may hear your doctor use the terms autosomal dominant cerebellar ataxia (ADCA) and spinocerebellar ataxia (SCA). ADCA is a broad umbrella term for hereditary ataxias passed down from one parent. SCAs are specific genetic subtypes that fall under this umbrella.

Many of these SCAs are caused by an abnormal repetition of CAG—a specific sequence of DNA building blocks (Cytosine, Adenine, and Guanine) that code for a protein. When this DNA sequence repeats too many times, it causes a “polyglutamine SCA” (such as SCA1, SCA2, SCA3, or SCA7) ^[3][4].

Crucially, the exact number that is considered “high” or “disease-causing” changes entirely depending on the specific SCA subtype you have ^[5][6]. A CAG count of 45 might be a significant expansion for one type of SCA, but closer to the normal range for another. Therefore, your specific number must always be interpreted alongside your specific SCA diagnosis.

What is Genetic Anticipation?

When the mutated gene that causes a CAG-repeat SCA is passed from parent to child, that section of repeating DNA is physically unstable. Because of this instability, the repeat number usually increases, or “expands,” from one generation to the next ^[7]. While the repeats can occasionally shrink (contract) when passed down, expansion is far more common.

This intergenerational expansion is the cause of genetic anticipation—a biological phenomenon where symptoms of a genetic condition appear at an earlier age, and often with greater severity, in successive generations ^[8][9]. If your CAG repeat number is higher than your parent’s, you are experiencing genetic anticipation.

Interestingly, which parent passes down the mutation can affect how much the repeat number changes. Expansions happen through either parent, but inheriting the gene from a father can sometimes lead to much larger “jumps” in the CAG repeat size compared to maternal inheritance ^[10][8].

How Does the Repeat Number Affect Your Prognosis?

The most direct and proven impact of a larger CAG repeat number is that it brings the age of symptom onset forward ^[11]. For example, if a parent developed balance issues in their 50s, a child with a higher repeat number might start noticing symptoms in their 30s or 40s.

A higher repeat number is also associated with a somewhat faster rate of clinical decline and a more severe presentation of symptoms ^[1][2]. However, doctors cannot look at your CAG repeat number and tell you exactly what your future holds. Your disease course is also heavily influenced by:

• Your specific SCA subtype: Different types of ataxia (like SCA1, SCA2, SCA3, or SCA7) have different average progression rates and symptom profiles ^[3].
• Other genetic modifiers: Your body’s DNA repair genes and other genetic factors play a significant role in how the disease behaves and progresses over time ^[12][13].

Navigating Your Results and Family Planning

Seeing a higher CAG number on your genetic test results compared to your parent’s can be overwhelming. It is entirely normal to feel anxious about what this means for your own future, as well as the risk to your children.

Remember that while your number is higher, predicting the exact course of ataxia remains complex. Connecting with a neurologist who specializes in movement disorders and a genetic counselor is the most important next step. A genetic counselor can help you contextualize these results, discuss the specific normal and expanded ranges for your SCA subtype, and talk through family planning options—such as in vitro fertilization (IVF) to prevent passing the mutation on, or testing strategies for adult children.